We are live on ! Find out more
P

Pfizer Portfolio holdings

AUM $239M
1-Year Est. Return 232.47%
This Fund
S&P 500
This Quarter Est. Return
+21.95%
1 Year Est. Return
+232.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$576M
AUM Growth
+$75.4M
Cap. Flow
-$776K
Cap. Flow %
-0.13%
Top 10 Hldgs %
96.54%
Holding
21
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
NXTC icon
NextCure
NXTC
+$776K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNTX icon
1
BioNTech
BNTX
$23.1B
$390M 67.6%
3,658,361
– –
ORIC icon
2
Oric Pharmaceuticals
ORIC
$1.11B
$54.6M 9.47%
5,376,344
– –
ARVN icon
3
Arvinas
ARVN
$517M
$25.4M 4.42%
3,457,815
– –
ALLO icon
4
Allogene Therapeutics
ALLO
$618M
$24.9M 4.32%
22,032,040
– –
TRML
5
DELISTED
Tourmaline Bio
TRML
$20.3M 3.53%
1,272,214
– –
WVE icon
6
Wave Life Sciences
WVE
$1.12B
$12.2M 2.12%
1,875,000
– –
PYXS icon
7
Pyxis Oncology
PYXS
$150M
$7.74M 1.34%
7,032,770
– –
CRDF icon
8
Cardiff Oncology
CRDF
$60.2M
$7.6M 1.32%
2,411,575
– –
BHVN icon
9
Biohaven
BHVN
$2.32B
$7.13M 1.24%
505,645
– –
SPRO icon
10
Spero Therapeutics
SPRO
$91.5M
$6.85M 1.19%
2,362,348
– –
CRBU icon
11
Caribou Biosciences
CRBU
$164M
$5.91M 1.03%
4,690,431
– –
CELC icon
12
Celcuity
CELC
$4.31B
$4.66M 0.81%
349,406
– –
ZURA icon
13
Zura Bio
ZURA
$518M
$3.12M 0.54%
2,970,022
– –
EPIX
14
DELISTED
ESSA Pharma
EPIX
$2.85M 0.49%
1,675,000
– –
ZNTL icon
15
Zentalis Pharmaceuticals
ZNTL
$364M
$1.11M 0.19%
953,834
– –
NXTC icon
16
NextCure
NXTC
$24.4M
$870K 0.15%
13,137
-144,510
-92% -$776K
ANTX icon
17
AN2 Therapeutics
ANTX
$169M
$758K 0.13%
715,295
– –
QTTB icon
18
Q32 Bio
QTTB
$255M
$414K 0.07%
277,777
– –
BOLT icon
19
Bolt Biotherapeutics
BOLT
$8.49M
$181K 0.03%
31,305
– –
DNA icon
20
Ginkgo Bioworks
DNA
$517M
$32.9K 0.01%
2,928
– –
SENS icon
21
Senseonics Holdings Inc
SENS
$267M
$20.7K ﹤0.01%
2,171
– –

Similar funds

DCC
Dow Chemical Company Midland, Michigan $239M AUM 13.16% 1-Year Est. Return
OCERS
Orange County Employees Retirement System Santa Ana, California $239M AUM
CWMGP
Capstone Wealth Management Group (Pennsylvania) Clarks Green, Pennsylvania $239M AUM 18.48% 1-Year Est. Return
WWA
Wealth Watch Advisors Englewood, Colorado $239M AUM 21.17% 1-Year Est. Return
MFC
Mechanics Financial Corp Mansfield, Ohio $239M AUM 25.61% 1-Year Est. Return
RCM
Robinson Capital Management Grosse Pointe Farms, Michigan $239M AUM 0.62% 1-Year Est. Return
TGIA
Torrey Growth & Income Advisors Del Mar, California $239M AUM
GCA
Genesee Capital Advisors Auburn, New York $239M AUM 20.45% 1-Year Est. Return

Pfizer's Q2 2025 Portfolio in Review

As of Q2 2025, Pfizer held 21 positions worth $576M, up 15% from $501M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 0%. Pfizer opened no new positions and made no exits, leaving the 21-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Pfizer's biggest Q2 2025 reduction was NextCure, cutting an estimated $776K.
  • Pfizer's ten largest holdings make up 97% of its $576M portfolio in Q2 2025.
  • Pfizer opened 0 new positions and closed 0 in Q2 2025.
  • Pfizer's portfolio value rose 15% quarter-over-quarter to $576M.

Based on Pfizer's 13F filing for Q2 2025, filed 11 Aug 2025.